News & Events about Aldeyra Therapeutics Inc.
Ticker Report
2 months ago
Aldeyra Therapeutics (NASDAQ:ALDX Get Rating) had its price target lifted by Citigroup from $23.00 to $28.00 in a research report sent to investors on Friday, The Fly reports. A number of other equities analysts have also recently commented on the stock. HC Wainwright reiterated a buy rating...
Aldeyra Therapeutics, Inc (NASDAQ:ALDX Get Rating) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 2,020,000 shares, an increase of 19.5% from the January 15th total of 1,690,000 shares. Based on an average ...
Ticker Report
3 months ago
Aldeyra Therapeutics, Inc (NASDAQ:ALDX Get Rating) saw a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 2,020,000 shares, a growth of 19.5% from the January 15th total of 1,690,000 shares. Approximately 3.6% of the shares of the...